Alvotech Warrant
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic art… Read more
Market Cap & Net Worth: Alvotech Warrant (ALVOW)
Alvotech Warrant (NASDAQ:ALVOW) has a market capitalization of $3.07K ($3.07K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22902 globally and #8049 in its home market, demonstrating a -9.64% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alvotech Warrant's stock price $0.33 by its total outstanding shares 9297 (9.30K).
Alvotech Warrant Market Cap History: 2022 to 2026
Alvotech Warrant's market capitalization history from 2022 to 2026. Data shows change from $8.65K to $3.07K (-23.75% CAGR).
Alvotech Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alvotech Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Alvotech Warrant's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $8.65K | $83.03 Million | -$513.58 Million | 0.00x | N/A |
| 2023 | $23.24K | $91.43 Million | -$551.73 Million | 0.00x | N/A |
| 2024 | $28.91K | $489.68 Million | -$231.86 Million | 0.00x | N/A |
Competitor Companies of ALVOW by Market Capitalization
Companies near Alvotech Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to Alvotech Warrant by market ranking:
- SMO (BK:SMO): Ranked #22893 globally with a market cap of $35.06 Million USD ( ฿1.22 Billion THB).
- Cosmax (KO:044820): Ranked #22894 globally with a market cap of $35.06 Million USD ( ₩51.34 Billion KRW).
- Prestige Biologics Co. Ltd. (KQ:334970): Ranked #22903 globally with a market cap of $35.01 Million USD ( ₩51.27 Billion KRW).
- MAGELLANIC CLOUD LTD (NSE:MCLOUD): Ranked #22904 globally with a market cap of $35.00 Million USD ( ₹3.03 Billion INR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #22893 | SMO | BK:SMO | $35.06 Million | ฿4.78 |
| #22894 | Cosmax | KO:044820 | $35.06 Million | ₩14570.00 |
| #22903 | Prestige Biologics Co. Ltd. | KQ:334970 | $35.01 Million | ₩2530.00 |
| #22904 | MAGELLANIC CLOUD LTD | NSE:MCLOUD | $35.00 Million | ₹22.16 |
Alvotech Warrant Historical Marketcap From 2022 to 2026
Between 2022 and today, Alvotech Warrant's market cap moved from $8.65K to $ 3.07K, with a yearly change of -23.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.07K | -49.21% |
| 2025 | $6.04K | -79.10% |
| 2024 | $28.91K | +24.40% |
| 2023 | $23.24K | +168.82% |
| 2022 | $8.65K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Alvotech Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.07K USD |
| MoneyControl | $3.07K USD |
| MarketWatch | $3.07K USD |
| marketcap.company | $3.07K USD |
| Reuters | $3.07K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.